Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Locally Advanced Rectal Carcinoma × envafolimab × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1 Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2 Biliary Tract Neoplasms 2 Rectal Neoplasms 1 Rare Tumour 1 Osteosarcoma 1 Locally Advanced Rectal Carcinoma 1 Gastrointestinal Stromal Tumors 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Renal Cell Carcinoma (aRCC) 1 Advanced Refractory Solid Tumors 1

Interventions

envafolimab 1 durvalumab 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05645094 2022-12-13

Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer

Fudan University

Not yet recruiting

GastrointestinalOther solid neoplasm

Locally Advanced Rectal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡